Masthead-Image-Right-min

Short-Term PAMA Relief: What Labs Must Do & Why Long-Term Reform Matters

The clock is ticking on imminent reporting requirements and the urgent need for lasting Medicare rate stability.

Continue Reading...

From Revenue to Operations: Our Most‑Watched Webinars for Lab Leaders

Strengthen revenue performance and reduce risk—watch on-demand now!

Continue Reading...

The End of an Era: FDA is Rescinding Long-Contested LDT Rule for Labs

Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories

Continue Reading...

From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks

With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny.

Continue Reading...

What's Next for LDTs? A Look Beyond the Ruling

Get the key takeaways from our expert-led webinar on the LDT final rule ruling—and why labs must stay vigilant as the story unfolds.

Continue Reading...